Lantheus share price today

(LNTH)

Lantheus share price is $89.29 & ₹7,587.51 as on 21 Dec 2024, 2.30 'hrs' IST

$89.29

▲

-2.66

(-2.89%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Lantheus share price in Dollar and Rupees. Guide to invest in Lantheus from India. Also see the sentimental analysis on Indian investors investing in Lantheus. Get details on the Indian mutual funds that are investing in Lantheus. Get Analyst recommendations and forecasts along with all the Lantheus's financials.

Lantheus share price movements

Today's Low: $88.56
Today's High: $91.62
$89.29
0.82%
Downside
Day's Volatility :3.34%
Upside
2.54%
52 Weeks Low: $50.20
52 Weeks High: $126.89
$89.29
43.78%
Downside
52 Weeks Volatility :60.44%
Upside
29.63%

Lantheus Returns

Period	Lantheus Holdings	Sector (Health Care)	Index (Russel 2000)
3 Months	-19.82%	-11.1%	0.0%
6 Months	13.09%	-6.0%	0.0%
1 Year	49.83%	2.7%	0.0%
3 Years	206.3%	0.6%	-19.7%

Lantheus Key Statistics

in dollars & INR

Previous Close	$91.94
Open	$91.05
Today's High	$91.62
Today's Low	$88.5607
Market Capitalization	$6.4B
Today's Volume	$1.9M
52 Week High	$126.8899
52 Week Low	$50.2
Revenue TTM	$1.5B
EBITDA	$548.1M
Earnings Per Share (EPS)	$6.02
PE Ratio	15.27
Profit Margin	28.57%
Quarterly Earnings Growth YOY	-0.05%
Return On Equity TTM	45.53%

How to invest in Lantheus from India?

It is very easy for Indian residents to invest directly in Lantheus from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lantheus stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lantheus or LNTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lantheus or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lantheus shares which would translate to 0.010 fractional shares of Lantheus as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Lantheus, in just a few clicks!

Returns in Lantheus for Indian investors in Rupees

Investment Value

₹1,00,000

Lantheus investment value today

Current value as on today

₹1,52,037

Returns

₹52,037

(+52.04%)

Returns from Lantheus Stock

₹49,841 (+49.84%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Lantheus

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Lantheus on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 2% more investors are searching Lantheus in the last 30 days versus the previous period.

Global Institutional Holdings in Lantheus

BlackRock Inc
12.36%
Vanguard Group Inc
10.67%
HHG PLC
5.16%
Farallon Capital Management, L.L.C.
4.25%
State Street Corp
3.62%
FMR Inc
3.50%

Analyst Recommendation on Lantheus

Buy

88%Buy

11%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Lantheus(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Lantheus

What analysts predicted

Upside of 50.85%

Current:

$89.29

Target:

$134.69

Insights on Lantheus

Price Movement
In the last 3 years, LNTH stock has moved up by 214.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 394.09M → 378.73M (in $), with an average decrease of 3.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 62.07M → 131.09M (in $), with an average increase of 52.7% per quarter

Lantheus Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$343.4M	↑ 3.62%
Net Income	$40.5M	↓ 67.16%
Net Profit Margin	11.8%	↓ 25.43%

	FY19	Y/Y Change
Revenue	$347.3M	↑ 1.15%
Net Income	$31.7M	↓ 21.84%
Net Profit Margin	9.12%	↓ 2.68%

	FY20	Y/Y Change
Revenue	$339.4M	↓ 2.28%
Net Income	$-13.5M	↓ 142.55%
Net Profit Margin	-3.97%	↓ 13.09%

	FY21	Y/Y Change
Revenue	$425.2M	↑ 25.28%
Net Income	$-71.3M	↑ 429.05%
Net Profit Margin	-16.76%	↓ 12.79%

	FY22	Y/Y Change
Revenue	$935.1M	↑ 119.91%
Net Income	$28.1M	↓ 139.38%
Net Profit Margin	3.0%	↑ 19.76%

	FY23	Y/Y Change
Revenue	$1.3B	↑ 38.65%
Net Income	$326.7M	↑ 1063.86%
Net Profit Margin	25.2%	↑ 22.2%

	Q2 FY23	Q/Q Change
Revenue	$321.7M	↑ 6.95%
Net Income	$94.1M	↓ 3453.44%
Net Profit Margin	29.26%	↑ 30.19%

	Q3 FY23	Q/Q Change
Revenue	$319.9M	↓ 0.55%
Net Income	$132.0M	↑ 40.18%
Net Profit Margin	41.24%	↑ 11.98%

	Q4 FY23	Q/Q Change
Revenue	$354.0M	↑ 10.64%
Net Income	$103.4M	↓ 21.66%
Net Profit Margin	29.2%	↓ 12.04%

	Q1 FY24	Q/Q Change
Revenue	$370.0M	↑ 4.51%
Net Income	$131.1M	↑ 26.78%
Net Profit Margin	35.43%	↑ 6.23%

	Q2 FY24	Q/Q Change
Revenue	$394.1M	↑ 6.52%
Net Income	$62.1M	↓ 52.64%
Net Profit Margin	15.75%	↓ 19.68%

	Q3 FY24	Q/Q Change
Revenue	$378.7M	↓ 3.9%
Net Income	$131.1M	↑ 111.19%
Net Profit Margin	34.61%	↑ 18.86%

	FY18	Y/Y Change
Profit	$174.9M	↑ 7.86%

	FY19	Y/Y Change
Profit	$174.8M	↓ 0.04%

	FY20	Y/Y Change
Profit	$138.8M	↓ 20.62%

	FY21	Y/Y Change
Profit	$187.7M	↑ 35.26%

	FY22	Y/Y Change
Profit	$581.7M	↑ 209.92%

	FY23	Y/Y Change
Profit	$709.5M	↑ 21.98%

	Q2 FY23	Q/Q Change
Profit	$202.6M	↑ 162.92%

	Q3 FY23	Q/Q Change
Profit	$200.0M	↓ 1.33%

	Q4 FY23	Q/Q Change
Profit	$229.9M	↑ 14.96%

	Q1 FY24	Q/Q Change
Profit	$251.8M	↑ 9.53%

	Q2 FY24	Q/Q Change
Profit	$255.8M	↑ 1.59%

	Q3 FY24	Q/Q Change
Profit	$242.1M	↓ 5.34%

	FY18	Y/Y Change
Operating Cash Flow	$61.2M	↑ 11.71%
Investing Cash Flow	$-19.1M	↑ 17.31%
Financing Cash Flow	$-4.7M	↓ 65.29%

	FY19	Y/Y Change
Operating Cash Flow	$80.4M	↑ 31.36%
Investing Cash Flow	$-22.1M	↑ 15.31%
Financing Cash Flow	$-78.9M	↑ 1589.82%

	FY20	Y/Y Change
Operating Cash Flow	$16.4M	↓ 79.6%
Investing Cash Flow	$-4.9M	↓ 77.73%
Financing Cash Flow	$-21.9M	↓ 72.29%

	FY21	Y/Y Change
Operating Cash Flow	$53.9M	↑ 228.84%
Investing Cash Flow	$3.7M	↓ 174.98%
Financing Cash Flow	$-39.3M	↑ 79.92%

	FY22	Y/Y Change
Operating Cash Flow	$281.8M	↑ 422.63%
Investing Cash Flow	$-276.5M	↓ 7608.74%
Financing Cash Flow	$311.7M	↓ 892.46%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-32.3M	↓ 129.74%
Investing Cash Flow	$-20.7M	↓ 53.5%
Financing Cash Flow	$-4.1M	↓ 53.27%

Lantheus Technicals Summary

Sell

Neutral

Buy

Lantheus is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Lantheus Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lantheus Holdings	2.25%	13.09%	49.83%	206.3%	263.09%
Neurocrine Biosciences Inc.	8.34%	1.35%	5.43%	59.49%	24.91%
Haleon Plc Spon Ads	1.47%	12.15%	18.9%	30.77%	30.77%
Zoetis Inc.	-6.72%	-4.07%	-15.46%	-31.76%	24.53%
Viatris Inc.	-5.51%	19.58%	17.56%	-5.51%	-23.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lantheus Holdings	15.27	15.27	0.61	6.81	0.46	0.17	NA	16.97
Neurocrine Biosciences Inc.	35.99	35.99	0.32	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.53	28.53	1.73	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.68	30.68	2.6	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lantheus Holdings	Buy	$6.4B	263.09%	15.27	28.57%
Neurocrine Biosciences Inc.	Buy	$13.7B	24.91%	35.99	17.21%
Haleon Plc Spon Ads	Buy	$44.1B	30.77%	28.53	10.75%
Zoetis Inc.	Buy	$73.8B	24.53%	30.68	26.55%
Viatris Inc.	Hold	$14.5B	-23.38%	224.4	-5.87%

About Lantheus

lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.

Organization	Lantheus
Employees	834
CEO	Mr. Brian A. Markison
Industry	Health Technology

Management People of Lantheus

Name	Title
Mr. Brian A. Markison	CEO & Director
Mr. Paul M. Blanchfield	President
Mr. Robert J. Marshall Jr., CFA	CFO & Treasurer
Dr. Jean-Claude Provost M.D.	Chief Science Officer
Mr. Daniel M. Niedzwiecki	Chief Administrative Officer, General Counsel & Corporate Secretary
Ms. Kimberly Brown	Chief Accounting Officer
Ms. Dorothy Barr	Senior Vice President of Manufacturing & Technical Operations
Ms. Lee Anne Howe	Chief Information Officer
Mr. Mark Richard Kinarney	Senior Director of Investor Relations
Ms. Linda S. Lennox	VP of Corporate Communications & Chief of Staff

Important FAQs about investing in Lantheus from India :

What is Lantheus share price today?

Lantheus share price today stands at $89.29, Open: $91.05 ; Previous Close: $91.94 ; High: $91.62 ; Low: $88.56 ; 52 Week High: $126.89 ; 52 Week Low: $50.20. The stock opens at $91.05, after a previous close of $91.94. The stock reached a daily high of $91.62 and a low of $88.56, with a 52-week high of $126.89 and a 52-week low of $50.20.

Can Indians buy Lantheus shares?

Yes, Indians can invest in the Lantheus (LNTH) from India.

With INDmoney, you can buy Lantheus at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Lantheus at zero transaction cost.

How can I buy Lantheus shares from India?

It is very easy to buy Lantheus from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lantheus be purchased?

Yes, you can buy fractional shares of Lantheus with INDmoney app.

What are the documents required to start investing in Lantheus stocks?

To start investing in Lantheus, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.